대원제약

003220KOSPI의약품 제조업

39.3 / 100

Reference Date: 2026-04-13

Financial Score11.0 / 40

News Sentiment13.3 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is undervalued vs. peers but the high debt ratio poses financial risk. Slightly down 2.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Daewon Pharmaceutical operates in pharmaceuticals, cosmetics, and health functional foods, focusing on CMO services, overseas exports, and the development of OTC drugs and health supplements. Key subsidiaries include Daewon Meditech (hearing aid sales), Daewon Pharmaceutical Vietnam (Southeast Asia market expansion), SD Biotech (cosmetics brand 'SNP'), and 'Ogam Shikdak' (a 2022-launched convenience food brand targeting online markets with products like 'Token Broth').

Number of Employees

1,349people

Average Salary

77.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 14.804.0Point

PBR

0.84Industry Average 1.044.0Point

In line with industry avg

ROE

-1.44Industry Average 4.420.0Point

Well below industry avg

Debt Ratio

44.70Industry Average 11.980.0Point

3.7x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲7.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼50.1% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.7% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 1Neutral 0Negative 0Average Sentiment Score 60

Positive
대원제약, 콜대원 새 광고 캠페인 '감기의 소리를 찾아서' 선보여
대원제약은 짜먹는 감기약 '콜대원'의 신규 광고 캠페인 '감기의 소리를 찾아서'를 선보이며 연간 캠페인으로 전환했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 10,300Won52-week high 14,02052-week low 10,030

1-month return2.0Point

1m -2.18% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral정기주주총회결과2026-03-26
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
Neutral감사보고서제출2026-03-18
Neutral사업보고서 (2025.12)2026-03-18